Revvity ROE 2010-2024 | RVTY

Current and historical return on equity (ROE) values for Revvity (RVTY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Revvity ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.25B $7.92B 3.22%
2024-06-30 $0.17B $7.87B 2.16%
2024-03-31 $0.15B $7.85B 1.92%
2023-12-31 $0.69B $7.87B 8.81%
2023-09-30 $0.74B $7.69B 9.58%
2023-06-30 $0.82B $7.87B 10.78%
2023-03-31 $0.96B $8.03B 12.97%
2022-12-31 $0.57B $7.38B 7.90%
2022-09-30 $0.63B $7.07B 8.84%
2022-06-30 $0.67B $7.17B 9.48%
2022-03-31 $0.74B $7.19B 11.61%
2021-12-31 $0.94B $7.14B 16.88%
2021-09-30 $1.13B $6.96B 23.93%
2021-06-30 $1.18B $4.24B 31.09%
2021-03-31 $1.07B $4.00B 30.80%
2020-12-31 $0.73B $3.74B 22.94%
2020-09-30 $0.41B $3.23B 14.03%
2020-06-30 $0.30B $2.97B 10.49%
2020-03-31 $0.23B $2.76B 8.26%
2019-12-31 $0.23B $2.81B 8.39%
2019-09-30 $0.23B $2.71B 8.80%
2019-06-30 $0.25B $2.71B 9.60%
2019-03-31 $0.25B $2.64B 9.58%
2018-12-31 $0.24B $2.59B 9.31%
2018-09-30 $0.13B $2.57B 4.97%
2018-06-30 $0.14B $2.52B 5.54%
2018-03-31 $0.28B $2.56B 11.16%
2017-12-31 $0.29B $2.50B 12.10%
2017-09-30 $0.40B $2.54B 17.09%
2017-06-30 $0.37B $2.44B 16.38%
2017-03-31 $0.23B $2.21B 10.53%
2016-12-31 $0.23B $2.15B 11.11%
2016-09-30 $0.24B $2.14B 11.31%
2016-06-30 $0.23B $2.09B 11.28%
2016-03-31 $0.22B $2.05B 10.51%
2015-12-31 $0.21B $2.11B 10.16%
2015-09-30 $0.18B $2.05B 8.46%
2015-06-30 $0.16B $2.12B 7.82%
2015-03-31 $0.16B $2.06B 7.93%
2014-12-31 $0.16B $2.04B 7.67%
2014-09-30 $0.19B $2.06B 9.48%
2014-06-30 $0.19B $2.06B 9.55%
2014-03-31 $0.17B $2.03B 8.66%
2013-12-31 $0.17B $1.99B 8.78%
2013-09-30 $0.08B $1.92B 4.45%
2013-06-30 $0.07B $1.86B 3.91%
2013-03-31 $0.08B $1.83B 4.21%
2012-12-31 $0.07B $1.94B 3.71%
2012-09-30 $0.00B $1.94B 0.16%
2012-06-30 $0.01B $1.89B 0.53%
2012-03-31 $0.01B $1.88B 0.31%
2011-12-31 $0.01B $1.84B 0.42%
2011-09-30 $0.39B $1.95B 20.07%
2011-06-30 $0.36B $1.96B 19.42%
2011-03-31 $0.39B $1.91B 21.83%
2010-12-31 $0.39B $1.93B 22.64%
2010-09-30 $0.13B $1.71B 7.93%
2010-06-30 $0.13B $1.64B 8.12%
2010-03-31 $0.10B $1.63B 5.97%
2009-12-31 $0.08B $1.63B 5.26%
Sector Industry Market Cap Revenue
Medical Medical Services $15.535B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00